Regulatory

Regulatory  ·  Weekly Dgest 12 Oct to 18 Oct 2024
SystImmune, Inc. announces FDA clearance of IND application for BL-M11D1 in relapsed/refractory Acute Myeloid Leukemia

Weekly Digest – October 2024 Weekly Digest – October 2024 14 Oct 2024: SystImmune, Inc. announces FDA clearance of IND application for BL-M11D1 in relapsed/refractory Acute Myeloid Leukemia SystImmune, Inc. announced that the FDA has cleared its IND application for […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Dgest 12 Oct to 18 Oct 2024
BlissBio receives IND approval from FDA for novel ADC BB-1712

Weekly Digest – October 2024 Weekly Digest – October 2024 16 Oct 2024: BlissBio receives IND approval from FDA for novel ADC BB-1712 BlissBio’s investigational new drug application for BB-1712, an antibody-drug conjugate targeting B7-H3, has been approved by the […]

by Sandhya Ramalingam

Continue Reading